Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Report for the period 1 January-30 June 2021

1 April– 30 June 2021 · Net sales amounted to SEK 2.81 m (2.81) · Net operating income was SEK 337,000 (-617,000) · The operating profit was SEK 8.67 m (-2.30) · The profit for the period was SEK 6.95 m (-14.03) · Earnings per share before and after dilution were SEK 13.90 (-28.06) 1 January– 30 June 2021 · Net sales amounted to SEK 5.42 m (5.49) · Net operating income was SEK -1.21 m (-2.45) · The operating loss was SEK 19.03 m (-12.07) · The loss for the period was SEK 22.39 m (-35.40) · Earnings per share before and after dilution were SEK -44.78 (-70.

Flowscape receives large SaaS order in the UK

In relation with the return to the UK offices, an existing customer is extending its licenses for Flowscape's "Desk Management Solution". This is part of opening up previously blocked workplaces, to prepare for higher occupancy in the offices. The total order value amounts to SEK 540,000 in annual SaaS revenues.During the pandemic, customers have blocked a large part of their desk spaces to ensure social distancing. Now that the UK has opened up the country, more and more customers see the need to return to full capacity in the offices - which requires additional desk licenses. "After a

BNP Paribas announces new CEO for BNP Paribas Group Denmark

BNP Paribas announces the appointment of Ulrik Ross as CEO for BNP Paribas Group Denmark and Head of CIB Denmark, effective 30th of August 2021. Ulrik will report to Eirik Winter, CEO for BNP Paribas Group Nordic Region. Ulrik will also be part of the Nordic Leadership TeamUlrik brings over 30 years’ of banking experience from Nordic Investment Bank, Merrill Lynch, Nomura, HSBC and various Danish financial institutions, including 18 years in London and 2 years in Finland. Most recently, Ulrik was a member of the Board of Directors and Chairman of the Audit Committee at NTG Nordic Transport

Ikano Bank AB (publ) Interim Report 30 June 2021

Results as expected, continued investments in digital solutions, and Ingka new part-owner“The first half of 2021 has been a successful phase in our strategic renewal journey. We are on our way to become a fully digitalised, sustainable bank. In the spring, our first product was successfully launched on the new platform. In June, we brought in Ingka as part-owner. The closer partnership with Ingka makes it possible to further accelerate the transformation of the Bank. Together, we now have even more power to accelerate towards the future.” Henrik Eklund, CEO, Ikano Bank AB (publ)

Invitation to Essity’s Capital Markets Day 2021

Welcome to Essity’s virtual Capital Markets Day for investors, analysts and the media on November 3, 2021, at 2:00 p.m.-5:00 p.m. CET.[Essity CMD 2021]As a leading innovative, digital and sustainable hygiene and health company, Essity will describe the company’s strategy and continued transformation journey, as well as its work to achieve the Group’s goal of profitable growth, net zero emissions by 2050 and improved well-being for people across the globe. The company’s management and employees will present the path forward with a focus on customer and consumers, innovation and brands,

Orkla ASA – Issuance of Commercial Paper

Orkla ASA has issued a commercial paper of NOK 500,000,000.Start date:                   1 September 2021 Maturity:                     1 December 2021 Coupon:                      0.39 % Organised by:             Handelsbanken Capital Markets         Orkla ASA Oslo, 27 August 2021   Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

Nokian Tyres: The growing EV car segment deserves premium tires to meet its demanding requirements

The Scandinavian tire manufacturer Nokian Tyres has been working hard to develop premium tires for electric cars  to satisfy the specific needs of the segment. Electric cars typically have high power outputs and their heavy battery packs cause them to weigh more than internal combustion engine (ICE) cars. Heavier cars also take longer to stop, putting increased emphasis on safety. Over the last decade, electric cars and hybrids have made a transition from a somewhat marginal part of the international automobile industry to one of the

BioStock: Invent Medic increases focus on marketing and product launch

For Invent Medic, the first half of 2021 has been focused on investments in the marketing of the company's first product Efemia bladder support. As the second quarter of the year is summed up, preparations are increasingly being made for the autumn launch of the next product in the series. BioStock contacted Invent Medic's CEO Karin Bryder to get her comment on the last quarter and find out what she expects from the autumn.Read the full article at biostock.se:https://www.biostock.se/en/2021/08/invent-medic-increases-focus-on-marketing-and-product-launch/This is a press release from

Veidekke ASA: To build Søndre Borgen Helsehus in Asker

Asker municipality has awarded Veidekke the contract to build the new health building at Borgen in Asker. This will be a new, detached building for 40 residents next to the existing health building at Borgen. The contract is a turnkey contract valued at NOK 132 million, excl. VAT.“We are very pleased to have won this project, as health buildings are a priority area for Veidekke. We have previously undertaken several good projects with Asker municipality, whom we perceive as a professional and good customer to work for, and it is therefore especially pleasing that we won the competition for

Supporting young people to develop skills

As part of the IKEA ambition to create a positive social impact, IKEA UK & Ireland and IKEA France are assisting young people through various initiatives to develop skills so they can live independently, increase employability and build relationships. These efforts are important for growth, connection and hope in a group facing countless challenges, especially considering the current effects of the pandemic. The countries’ partnerships reflect the IKEA vision to create a better everyday life for the many people.IKEA UK & Ireland helps young people who leave the care system One of the many

Read original

Fidesmo enables the world's first passive ring with dual payment scheme support

Fidesmo’s contactless wearable partner TAPSTER is now launching the world’s first passive payment ring with Mastercard and Visa tokenization. – Thanks to Fidesmo Pay’s support for both Mastercard and Visa, we are able to offer dual payment scheme support on the rings, which is fantastic and a great step forward, says Tobias Ericsson, CEO and Co-founder of TAPSTER.The Swedish contactless wearable brand TAPSTER now expands its range with the world’s first passive payment ring with dual payment scheme support, enabled by the payment service Fidesmo Pay. Fidesmo is the only token requestor

Lars Åleby new Cluster Director for Electronics at Dacke Industri AB

Our growth within Electronics has been strong and Dacke Industri has been searching for someone to manage the Electronics Cluster.Lars Åleby has worked with industrial sales (Business to Business) throughout his professional life, both with components and systems in several industries such as hydraulics, industrial automation, commercial vehicles, lighting, and more. Since 2000, Lars has held CEO positions in manufacturing and distributing companies in both Europe and Asia. In 2004, Lars was employed by KAMIC Group, where he held several positions, most recently as Division Manager for the “

Sitowise Group Plc: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Stock Exchange Release 27 August 2021, at 10:10 a.m. (EEST) Sitowise Group Plc (the "Company") has today received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Försäkringsaktiebolaget Avanza Pension, according to which Försäkringsaktiebolaget Avanza Pension indirect holding of the shares and votes of the Company increased above the threshold of 5 percent on 25 August 2021. According to the notification, The Capital Group Companies, Inc. holds a total of 1,960,089 shares corresponding to 5.53 percent of the Company’s shares and

Prostatype Genomics AB has completed a directed share issue of approximately SEK 24.7 million

Prostatype Genomics AB (“Prostatype” or “the Company”) hereby announces that the Company has completed a directed share issue of approximately SEK 24.7 million in accordance with the intention communicated to the market through a press release yesterday, August 26[th], 2021.The board of directors of Prostatype has, based on the authorization granted by the annual general meeting on the 16[th] of June 2021, and as indicated in the Company’s press release yesterday, decided to carry out a directed share issue through which the Company is provided approximately SEK 24.7 million. The

Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress

Oslo, Norway, 27 August 2021 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that the abstract “A pilot study of Engineered Adenovirus ONCOS-102 in combination with pembrolizumab (pembro) in checkpoint inhibitor refractory advanced or unresectable melanoma” will be presented as an e-poster at the European Society for Medical Oncology (ESMO) congress by Dr Alexander N. Shoushtari, Memorial Sloan Kettering Cancer Center. E-poster A pilot study of Engineered Adenovirus ONCOS-102 in

DanCann Pharma A/S publishes Q2-2021 report

COPENHAGEN, Denmark, 28 May 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby today releases its results for the period 1 April – 30 June 2021 (the “period”). The Q2-2021 report is available as an attached document to this press release and on www.dancann.com.Key figures Q2 2021 KDKK 01/04/21 01/04/20 30/06/20 01/01/21 30/06/21 01/01/20 30/06/20 30/06/21Net sales 0 0 0 0Operating -3,771 -1,237 -6,362 -1,499profit(EBIT)

BEWI ASA – Mandatory notification of trade and flagging announcement

Frøya Invest AS, a related party of CEO Christian Bekken, a PDMR of BEWI ASA, has on 27 August 2021, purchased a total of 6,779,661 shares from Verdane ETF III SPV K/S at NOK 29,50 per share. Following the transaction, Frøya Invest AS holds 95,112,813 shares. In addition, EBE Eiendom AS, also related to the Bekken family, owns 2,529,637 shares, and Christian Bekken holds 5,952 shares privately, summing up to a total holding of 97,648,402 shares, representing 62.35 per cent of the total outstanding shares in BEWI ASA. Christian Bekken also holds 250,000 options in BEWI ASA. Please see the

SynAct Pharma: Interim Report January-June 2021 August 27, 2021 (Q2 2021 Report included)

“Positive data of AP1189 in Covid-19 patients bodes well for the future. The hard work at the start of the year continued in the second quarter as SynAct Pharma made additional progress on its pipeline. The Covid-19 pandemic has certainly added complexity, but we have clear priorities, and our attractive project pipeline is progressing well. Our future is bright, and the second half of 2021 promises to be another busy period for us,” said SynAct Pharma’s CEO Jeppe Øvlesen.Summary of Half-Year 2021 interim report Second quarter (2021-04-01 – 2021-06-30) · Consolidated net sales

BioStock: Show of resilience from BiBBInstruments during Q2

Despite the challenges driven by the pandemic and some production issues during the first half of 2021, Swedish medtech BiBBInstruments has managed to keep to the scheduled clinical timelines for evaluating the world’s first CE-marked electric biopsy instrument - EndoDrill Model X. BioStock reached out to CEO Fredrik Lindblad for a comment.Read the full interview with Fredrik Lindblad at biostock.se: https://www.biostock.se/en/2021/08/show-of-resilience-from-bibbinstruments-during-q2/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se (

Omnicar Holding AB Q2 2021 report

Dear shareholders  Exactly one year ago, we launched the idea of our new mobile workshop concept and on 1 October 2020 our very first mobile service van rolled onto the streets - our Q2 report 2021 numbers reflects some of our accomplishments  Now, 12 months later, we are delighted to have reached the following key milestones: ·85% revenue growth in Q2 2021 compared to same periode last year ·The best customer satisfaction in the industry · Five service vans in the Greater Copenhagen area – number six is on its way · New CEO for Omnicar Holding and Omnicarservice

BioStock: Iconovo’s partner explores opportunities in Bangladesh

Together with ISR, Iconovo is developing an inhaled Covid-19 vaccine in ICOone and a nasal version in ICOone Nasal. ISR has now signed a MoU agreement with the CRO Bangladesh Clinical Trials for a clinical phase I study with the vaccine, as well as with UniMed UniHealth Pharmaceuticals for manufacturing and distribution in Bangladesh. However, these agreements are only declarations of intent, not binding agreements, but they are nevertheless good news for Iconovo as it means significant progress within the vaccine project.Read the full article at biostock.se: https://www.biostock.se/en/

Redwood Pharma AB (publ) Quarterly Report January – June 2021

NASDAQ FIRST NORTH GROWTH MARKET:REDW.ST, REDWOODPHARMA.COM Period 1 January–30 June 2021 · The company’s net revenue for the period totalled kSEK 0 (0). · Operating profits for the period totalled kSEK -10,916 (-8,026). · Earnings per share for the period were SEK -0.41 (-0.54). Period 1 April –30 June 2021 · The company’s net revenue for the period totalled kSEK 0 (0). · Operating profits for the period totalled kSEK -6,981 (-3,594). · Earnings per share for the period were SEK -0.34 (-0.24). Significant events during the period · Redwood Pharma

There are no items matching the current filter
There are no more items matching the current filter
Back to top